TrueBlue (TBI) PT Raised to $26 at BMO Capital
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $8.75 -3.42%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
BMO Capital analyst Jeffrey Silber raised the price target on TrueBlue (NYSE: TBI) to $26.00 (from $25.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- The Lovesac Co. (LOVE) PT Lowered to $18 at DA Davidson as Guidance Lowered
- Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
